Dosing of rivaroxaban by indication: getting the right dose for the patient

Expert Opinion on Drug Metabolism & Toxicology
Gines EscolarEduardo Arellano-Rodrigo

Abstract

Vitamin K antagonists were the only oral anticoagulants available for several decades, but they require frequent coagulation monitoring and dose adjustment. The direct oral anticoagulants rivaroxaban , dabigatran, apixaban, and, most recently, edoxaban have been approved for the management of specific thromboembolic indications. This review will provide a brief overview of the cell-based coagulation model, the main determinants of arterial and venous thrombosis, and the pharmacological rationale and clinical evidence for the different dosing regimens of rivaroxaban. Published articles indexed on PubMed and Medline covering arterial and venous thrombi pathophysiology, pharmacokinetics, and pharmacodynamics of rivaroxaban, and Phase II and Phase III clinical studies with rivaroxaban as well as real-world evidence were analyzed. Education on pharmacokinetic/pharmacodynamic characteristics, as well as how to manage adverse events, is needed to increase physician knowledge and confidence in using direct oral anticoagulants, as specifically discussed for rivaroxaban in this article. The continued uptake of direct oral anticoagulants in clinical practice depends on understanding of the clinical evidence and reassurance provided by eme...Continue Reading

References

Jan 23, 1992·The New England Journal of Medicine·V FusterJ H Chesebro
Oct 19, 2002·BMJ : British Medical Journal·Alexander G G TurpieGregory Y H Lip
Sep 18, 1964·Science·E W DAVIE, O D RATNOFF
Feb 11, 2005·JAMA : the Journal of the American Medical Association·Jean-Noel FiessingerUNKNOWN THRIVE Treatment Study Investigators
Mar 8, 2005·Journal of Thrombosis and Haemostasis : JTH·E PerzbornA Straub
Sep 20, 2005·Journal of the American College of Cardiology·Valentin FusterJuan J Badimon
Oct 4, 2005·Clinical Pharmacology and Therapeutics·Dagmar KubitzaGeorg Wensing
Jan 18, 2006·Journal of Thrombosis and Haemostasis : JTH·B I ErikssonUNKNOWN ODIXa-HIP Study Investigators
Mar 8, 2007·The Journal of the American Academy of Orthopaedic Surgeons·Richard J Friedman
Sep 15, 2007·The New England Journal of Medicine·UNKNOWN van Gogh InvestigatorsGary E Raskob
Feb 22, 2008·Nature·Nigel Mackman
Feb 26, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·John A Heit
Jun 27, 2008·The New England Journal of Medicine·Bengt I ErikssonUNKNOWN RECORD1 Study Group
Jun 27, 2008·The New England Journal of Medicine·Michael R LassenUNKNOWN RECORD3 Investigators
Aug 22, 2008·Current Medical Research and Opinion·Dagmar KubitzaWolfgang Mueck
Jun 13, 2009·Thrombosis Research·José A López, Junmei Chen
Jul 3, 2009·Journal of Cardiovascular Medicine·Elaine M Hylek
Oct 7, 2009·Thrombosis and Haemostasis·Gerhard J JohnsonRonald R Bach
Jan 12, 2010·Thrombosis and Haemostasis·Paolo GreseleRino Migliacci
Feb 16, 2010·The American Journal of Cardiology·Jan MenkeJörg Larsen
Oct 22, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·UNKNOWN JCS Joint Working Group
Nov 3, 2010·Annual Review of Physiology·Edwin G Bovill, Albert van der Vliet
Dec 7, 2010·The New England Journal of Medicine·Rupert BauersachsSebastian Schellong
Dec 18, 2010·Nature Reviews. Drug Discovery·Elisabeth PerzbornFrank Misselwitz
Jan 13, 2011·Thrombosis and Haemostasis·Alexander G G Turpie, Charles Esmon
Apr 7, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Hirotsugu AtarashiUNKNOWN J-RHYTHM Registry Investigators
May 14, 2011·Circulation Research·A Phillip Owens, Nigel Mackman
Jul 22, 2011·Canadian Journal of Surgery. Journal Canadien De Chirurgie·William D Fisher
Aug 13, 2011·The New England Journal of Medicine·Manesh R PatelUNKNOWN ROCKET AF Investigators

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Arteriosclerosis, Thrombosis, and Vascular Biology
Gerald A Soff
Mayo Clinic Proceedings
Wilson I GonsalvesMrinal M Patnaik
Current Neurology and Neuroscience Reports
Michael Levine, Joshua N Goldstein
© 2021 Meta ULC. All rights reserved